Phaseline

Companies › Shenzhen Ausa Pharmed

Shenzhen Ausa Pharmed: clinical trials, targets and expected readouts

2 active drug programs in 8 registered trials: 6 Phase 4, 1 Phase 3, 1 Phase 2; Cardiovascular, Neurology; next expected readout Jun 2029.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
5-methyltetrahydrofolate (5-MTHF)
Active form of folate; methyl donor for homocysteine remethylation
–Phase 4HypertensionJun 2029
Amlodipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Hypertension; Atrial Fibrillation; Diabetes Mellitus, Type 2; Stroke …Jun 2029

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06424834AmlodipinePhase 2Angina PectorisCardiovascularDec 2026
NCT04111419AmlodipinePhase 4Atrial FibrillationCardiovascularDec 2026
NCT04111419AmlodipinePhase 4Atrial FibrillationCardiovascularDec 2026
NCT03264352AmlodipinePhase 4Diabetes Mellitus, Type 2CardiovascularSep 2028
NCT04974151AmlodipinePhase 4HypertensionCardiovascularJun 2029
NCT049741515-methyltetrahydrofolate (5-MTHF)Phase 4HypertensionCardiovascularJun 2029
NCT05155137AmlodipinePhase 3StrokeNeurologyDec 2029
NCT04974138AmlodipinePhase 4HypertensionCardiovascularJun 2030

Targets

Ion channels (1)

Companies with the same targets

Xenon Pharmaceuticals Praxis Precision Medicines HB BioTech Encoded Therapeutics Biohaven Therapeutics TLC Biopharmaceuticals Grace Therapeutics LXO Ireland Jiangsu HengRui Medicine Industrial Farmacéutica Cantabria

Companies built like this

Grace Therapeutics SPH Qingdao Growful Pharmacetical MedTrace Pharma CeleCor Therapeutics CSPC Mingfule Pharmaceutical (Guangzhou)

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.